The potential role of follicle-stimulating hormone in the cardiovascular, metabolic, skeletal, and cognitive effects associated with androgen deprivation therapy

by Crawford, E. David, M.D, Schally, Andrew V., Ph.D., M.Dhc. (Multi), D.Sc., hc, Pinthus, Jehonathan H., M.D., Ph.D, Block, Norman L., M.D, Rick, Ferenc G., M.D., Ph.D, Garnick, Marc B., M.D, Eckel, Robert H., M.D, Keane, Thomas E., M.B.B.Ch., F.R.C.S.I., F.A.C.S, Shore, Neal D., M.D., F.A.C.S., C.P.I, Dahdal, David N., M.S., Ph.D, Beveridge, Thomas J.R., M.Sc., Ph.D, Marshall, Dennis C., R.N., M.S., Ph.D
Published in Urologic oncology

GnRH antagonist associates with less adiposity and reduced characteristics of metabolic syndrome and atherosclerosis compared with orchiectomy and GnRH agonist in a preclinical mou...

by Hopmans, Sarah N., M.Sc, Duivenvoorden, Wilhelmina C.M., Ph.D, Werstuck, Geoff H., Ph.D, Klotz, Laurence, M.D, Pinthus, Jehonathan H., M.D., Ph.D
Published in Urologic oncology

Thromboembolic events in patients with urothelial carcinoma undergoing neoadjuvant chemotherapy and radical cystectomy

by Zareba, Piotr, M.D., M.P.H, Patterson, Laurel, B.Sc, Pandya, Rishikesh, M.D, Margel, David, M.D., Ph.D, Hotte, Sebastien J., M.D., M.Sc, Mukherjee, Som D., M.D, Elavathil, Leelamma, M.D, Daya, Dean, M.D, Shayegan, Bobby, M.D, Pinthus, Jehonathan H., M.D., Ph.D
Published in Urologic oncology

Cardiovascular risk with androgen deprivation therapy for prostate cancer: Potential mechanisms

by Tivesten, Åsa, M.D., Ph.D, Pinthus, Jehonathan H., M.D, Clarke, Noel, Ch.M., FRCS (Urol), Duivenvoorden, Wilhelmina, Ph.D, Nilsson, Jan, M.D., Ph.D
Published in Urologic oncology